(BGS) B&G Foods - Overview
Stock: Frozen Vegetables, Canned Vegetables, Cooking Oils, Spices, Baking Mixes
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 15.97% |
| Yield on Cost 5y | 3.59% |
| Yield CAGR 5y | -20.47% |
| Payout Consistency | 94.0% |
| Payout Ratio | 10.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 52.0% |
| Relative Tail Risk | -14.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.20 |
| Alpha | -6.66 |
| Character TTM | |
|---|---|
| Beta | 0.161 |
| Beta Downside | 0.139 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.97% |
| CAGR/Max DD | -0.24 |
Description: BGS B&G Foods December 29, 2025
B&G Foods Inc. (NYSE:BGS) is a diversified manufacturer and distributor of shelf-stable, frozen, and specialty food products, as well as household items, serving the United States, Canada, and Puerto Rico.
The company’s portfolio spans a wide range of categories-including canned vegetables, cooking oils, hot cereals, sauces, dressings, and snack foods-under well-known brands such as Green Giant, Crisco, Ortega, and Grandma’s.
Distribution is executed both directly and through a network of independent brokers, reaching supermarket chains, food-service operators, mass merchants, warehouse clubs, and specialty outlets.
Key performance indicators to watch include net sales growth (historically low-single-digit), operating margin compression due to rising commodity costs, and inventory turnover, which has trended below industry averages, suggesting potential supply-chain inefficiencies.
Sector drivers that materially affect B&G include commodity price volatility (especially for corn, soy, and wheat), shifting consumer demand toward private-label and value-oriented products, and the broader inflationary environment that pressures discretionary food spending.
Given the company’s reliance on a large brand portfolio and thin margins, a thorough examination of its price-elasticity and cost-management initiatives is essential before forming an investment thesis.
For a deeper quantitative dive, you might explore B&G’s detailed financials and valuation metrics on ValueRay to see how the stock stacks up against peers.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -250.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -1.50 > 1.0 |
| NWC/Revenue: 30.53% < 20% (prev 17.60%; Δ 12.93% < -1%) |
| CFO/TA 0.03 > 3% & CFO 86.3m > Net Income -250.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 3.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (80.0m) vs 12m ago 0.74% < -2% |
| Gross Margin: 21.44% > 18% (prev 0.22%; Δ 2122 % > 0.5%) |
| Asset Turnover: 57.87% > 50% (prev 57.31%; Δ 0.57% > 0%) |
| Interest Coverage Ratio: -1.21 > 6 (EBITDA TTM -100.6m / Interest Expense TTM 151.2m) |
Altman Z'' 1.58
| A: 0.19 (Total Current Assets 816.9m - Total Current Liabilities 254.9m) / Total Assets 2.94b |
| B: 0.16 (Retained Earnings 465.0m / Total Assets 2.94b) |
| C: -0.06 (EBIT TTM -182.6m / Avg Total Assets 3.18b) |
| D: 0.19 (Book Value of Equity 470.7m / Total Liabilities 2.47b) |
| Altman-Z'' Score: 1.58 = BB |
Beneish M -3.13
| DSRI: 1.07 (Receivables 169.1m/167.8m, Revenue 1.84b/1.96b) |
| GMI: 1.02 (GM 21.44% / 21.87%) |
| AQI: 0.96 (AQ_t 0.62 / AQ_t-1 0.64) |
| SGI: 0.94 (Revenue 1.84b / 1.96b) |
| TATA: -0.11 (NI -250.5m - CFO 86.3m) / TA 2.94b) |
| Beneish M-Score: -3.13 (Cap -4..+1) = AA |
What is the price of BGS shares?
Over the past week, the price has changed by +17.62%, over one month by +25.98%, over three months by +8.19% and over the past year by -0.86%.
Is BGS a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 5
- Sell: 0
- StrongSell: 2
What are the forecasts/targets for the BGS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 4.2 | -18.3% |
| Analysts Target Price | 4.2 | -18.3% |
| ValueRay Target Price | 5.1 | -1.2% |
BGS Fundamental Data Overview February 03, 2026
P/S = 0.1899
P/B = 0.7289
P/EG = 7.93
Revenue TTM = 1.84b USD
EBIT TTM = -182.6m USD
EBITDA TTM = -100.6m USD
Long Term Debt = 2.02b USD (from longTermDebt, last quarter)
Short Term Debt = 19.6m USD (from shortTermDebt, last quarter)
Debt = 2.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.01b USD (from netDebt column, last quarter)
Enterprise Value = 2.36b USD (349.6m + Debt 2.07b - CCE 60.9m)
Interest Coverage Ratio = -1.21 (Ebit TTM -182.6m / Interest Expense TTM 151.2m)
EV/FCF = 43.12x (Enterprise Value 2.36b / FCF TTM 54.8m)
FCF Yield = 2.32% (FCF TTM 54.8m / Enterprise Value 2.36b)
FCF Margin = 2.97% (FCF TTM 54.8m / Revenue TTM 1.84b)
Net Margin = -13.61% (Net Income TTM -250.5m / Revenue TTM 1.84b)
Gross Margin = 21.44% ((Revenue TTM 1.84b - Cost of Revenue TTM 1.45b) / Revenue TTM)
Gross Margin QoQ = 22.50% (prev 20.49%)
Tobins Q-Ratio = 0.80 (Enterprise Value 2.36b / Total Assets 2.94b)
Interest Expense / Debt = 1.83% (Interest Expense 38.0m / Debt 2.07b)
Taxrate = 21.0% (US default 21%)
NOPAT = -144.2m (EBIT -182.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.20 (Total Current Assets 816.9m / Total Current Liabilities 254.9m)
Debt / Equity = 4.40 (Debt 2.07b / totalStockholderEquity, last quarter 470.7m)
Debt / EBITDA = -19.99 (negative EBITDA) (Net Debt 2.01b / EBITDA -100.6m)
Debt / FCF = 36.73 (Net Debt 2.01b / FCF TTM 54.8m)
Total Stockholder Equity = 502.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -7.88% (Net Income -250.5m / Total Assets 2.94b)
RoE = -49.85% (Net Income TTM -250.5m / Total Stockholder Equity 502.5m)
RoCE = -7.24% (EBIT -182.6m / Capital Employed (Equity 502.5m + L.T.Debt 2.02b))
RoIC = -5.74% (negative operating profit) (NOPAT -144.2m / Invested Capital 2.51b)
WACC = 2.18% (E(349.6m)/V(2.42b) * Re(6.51%) + D(2.07b)/V(2.42b) * Rd(1.83%) * (1-Tc(0.21)))
Discount Rate = 6.51% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.87%
[DCF Debug] Terminal Value 81.45% ; FCFF base≈78.8m ; Y1≈53.7m ; Y5≈26.5m
Fair Price DCF = N/A (negative equity: EV 836.9m - Net Debt 2.01b = -1.17b; debt exceeds intrinsic value)
EPS Correlation: -61.35 | EPS CAGR: -28.35% | SUE: -4.0 | # QB: 0
Revenue Correlation: -63.25 | Revenue CAGR: -6.79% | SUE: 0.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.04 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=0.51 | Chg30d=+0.010 | Revisions Net=+1 | Growth EPS=+0.9% | Growth Revenue=-2.9%